Scientists hunt for clues to better treat HPV throat cancer
NCT ID NCT06821243
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is collecting blood and tumor samples from 40 people with HPV-related oropharynx cancer to find biological markers that could predict how the disease will progress. Researchers will measure HPV DNA levels in the blood and analyze immune cells to better understand the body's response. The goal is to use this information to guide more personalized treatments in the future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF OROPHARYNX are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IRCCS National Cancer Institute "Regina Elena"
RECRUITINGRome, Rome, 00144, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.